RocketTickers

MNK Announce FDA Fast Track Designation

Long
NYSE:MNK   None
MNK: Mallinckrodt plc
2018-08-23 06:45:00
Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.